Inhaled nitric oxide for HAPE treatment trial
Part of Lungs & breathing clinical trials.
This trial tests if inhaled nitric oxide helps people with high-altitude pulmonary edema (fluid in the lungs from high altitude). It may offer a new treatment option for those with mild to moderate symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must have a recent three-to-nine point score on the Lake Louise mountain sickness scale.
- Your chest X-ray must show lung texture changes or cloudy spots in both lower lungs.
- You cannot have serious heart, lung, or bleeding conditions, or have used certain blood pressure medicines in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether high-flow oxygen (delivered through a special nasal tube) works better than standard oxygen therapy for a condition called high-altitude pulmonary edema (HAPE)—fluid buildup in the lungs caused by rapid ascent to high altitude. The study aims to see which approach helps patients breathe better and recover faster.
This trial tests new ways to diagnose and treat severe altitude sickness, which can cause fluid in the lungs or swelling in the brain. It aims to improve care for people who get very sick after climbing to high altitudes quickly.
This trial tests whether inhaled nitric oxide can help people with severe obesity who are on a breathing machine because their lungs aren't getting enough oxygen. It aims to see if this treatment improves oxygen levels and recovery.
This study looks at how the right side of the heart responds to low oxygen levels in people who have had high altitude pulmonary edema (HAPE) in the past. It will help researchers better understand right heart function.
This trial tests whether inhaled nitric oxide gas can help full-term newborns who have severe breathing problems and high blood pressure in their lungs. It aims to improve oxygen levels and reduce the need for more intensive support.
This trial tests whether a gas called nitric oxide, breathed in through the nose or mouth, can help people with moderate to severe COPD. It could improve breathing and quality of life.
Hear when a new High Altitude Pulmonary Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.